AI and Algorithms’ Invisible Hand on Our Finances

Artificial Intelligence's role in financial decision-making raises concerns over biases and data transparency.

Companies are increasingly relying on algorithms and artificial intelligence to make critical decisions about financial products, employment applications, and insurance premiums. These tools, when designed fairly, have the potential to reduce human biases in decision-making, enabling broader access to credit and opportunities. However, when flawed, they risk causing significant harm. Decisions made by AI systems can often be opaque, leaving consumers without understanding the data or factors that contributed to the decision.

There is significant concern over the black-box nature of AI systems used in financial decisions. Consumer advocates warn of biases in AI models, where data used can be unrepresentative or inaccurate, skewing outcomes negatively for certain demographic groups. The potential for such biases is particularly worrisome in contexts such as lending and insurance, where proxies like zip codes may inadvertently discriminate based on race or economic status.

Amid these challenges, there is a call for regulatory frameworks to ensure transparency and fairness in AI-driven decision processes. Proposals include mandatory disclosures when AI is involved in key decisions, company accountability in explaining decisions, and routine bias testing of AI models. The European Union’s AI Act serves as a benchmark, with advocates urging the U.S. to adopt similar regulations to protect consumers and ensure AI’s responsible use.

73

Impact Score

Crescent library brings privacy to digital identity systems

Crescent is a cryptographic library that adds unlinkability to common digital identity formats, preventing tracking across credential uses while preserving selective disclosure. It supports JSON Web Tokens and mobile driver’s licenses without requiring issuers to change their systems.

Artificial Intelligence-powered remote drug testing removes barriers to recovery

Q2i and King’s College London are collaborating to evaluate an Artificial Intelligence-powered at-home drug testing system aimed at people recovering from opioid use disorder. The solution delivers digitally observed, clinically reliable results and pairs testing with contingency management and telehealth to reduce logistical barriers to care.

Contact Us

Got questions? Use the form to contact us.

Contact Form

Clicking next sends a verification code to your email. After verifying, you can enter your message.